BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 18632233)

  • 1. Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
    Taguchi T; Tsukuda M; Mikami Y; Matsuda H; Tanigaki Y; Horiuchi C; Nishimura G; Nagao J
    Auris Nasus Larynx; 2009 Apr; 36(2):199-204. PubMed ID: 18632233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy.
    Taguchi T; Nishimura G; Takahashi M; Komatsu M; Sano D; Sakuma N; Arai Y; Yamashita Y; Shiono O; Hirama M; Sakuma Y; Ishitoya J; Hata M; Ogino I; Oridate N
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):837-43. PubMed ID: 23959463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of concurrent chemoradiotherapy for maxillary sinus squamous cell carcinoma patients.
    Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Satake K; Taguchi T; Takahashi M; Kawakami M; Hanamura H; Watanabe M; Utsumi A
    Auris Nasus Larynx; 2009 Oct; 36(5):547-54. PubMed ID: 19097833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
    Adelstein DJ; Saxton JP; Rybicki LA; Esclamado RM; Wood BG; Strome M; Lavertu P; Lorenz RR; Carroll MA
    J Clin Oncol; 2006 Mar; 24(7):1064-71. PubMed ID: 16505425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MASPIN's prognostic role in patients with advanced head and neck carcinoma treated with primary chemotherapy (carboplatin plus vinorelbine) and radiotherapy: preliminary evidence.
    Marioni G; Koussis H; Gaio E; Giacomelli L; Bertolin A; D'Alessandro E; Scola A; Ottaviano G; de Filippis C; Jirillo A; Staffieri A; Blandamura S
    Acta Otolaryngol; 2009 Jul; 129(7):786-92. PubMed ID: 18819022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Attempts to improve organ preservation in patients with squamous cell carcinoma of the head and neck].
    Taguchi T; Tsukuda M
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2030-4. PubMed ID: 16352924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose intra-arterial cisplatin therapy followed by radiation therapy for advanced squamous cell carcinoma of the head and neck.
    Wilson WR; Siegel RS; Harisiadis LA; Davis DO; Nguyen HH; Bank WO
    Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):809-12. PubMed ID: 11448355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H; Tsukuda M; Taguchi T
    Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent chemoradiotherapy with carboplatin and uracil-f tegafur (UFT) for patients with poor performance status with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori H; Tsukuda M; Taguchi T
    Acta Otolaryngol; 2007 Oct; 127(10):1099-104. PubMed ID: 17851890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The status of sequential chemo-/radiotherapy in inoperable head and neck cancers. Personal results and review of the literature].
    Volling P
    HNO; 1991 Jul; 39(7):254-9. PubMed ID: 1938489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
    Lavertu P; Adelstein DJ; Myles J; Secic M
    Laryngoscope; 2001 Nov; 111(11 Pt 1):1878-92. PubMed ID: 11801963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation.
    Nishimura G; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Kawakami M; Watanabe M; Niho T; Abo H; Yamomoto S
    Anticancer Res; 2009 Feb; 29(2):661-6. PubMed ID: 19331217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectable oral squamous cell carcinoma.
    Kurita H; Koike T; Miyazawa H; Uehara S; Kobayashi H; Kurashina K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):915-21. PubMed ID: 16835480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of prognostic variables among patients with locally advanced head and neck cancer treated with late chemo-intensification protocol: impact of nodal density and total tumor volume.
    Chufal KS; Rastogi M; Srivastava M; Pant MC; Bhatt ML; Srivastava K
    Jpn J Clin Oncol; 2006 Sep; 36(9):537-46. PubMed ID: 16905755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment results and prognostic factors for advanced squamous cell carcinoma of the hypopharynx treated with concurrent chemoradiotherapy.
    Taguchi T; Nishimura G; Takahashi M; Komatsu M; Sano D; Sakuma N; Yabuki K; Arai Y; Takahashi H; Hata M; Koike I; Oridate N
    Cancer Chemother Pharmacol; 2014 Jun; 73(6):1147-54. PubMed ID: 24658628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
    Tai SK; Yang MH; Wang LW; Tsai TL; Chu PY; Wang YF; Huang JL; Chang SY
    Jpn J Clin Oncol; 2008 Aug; 38(8):521-7. PubMed ID: 18697758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
    Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
    Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer.
    Goguen LA; Posner MR; Tishler RB; Wirth LJ; Norris CM; Annino DJ; Sullivan CA; Li Y; Haddad RI
    Arch Otolaryngol Head Neck Surg; 2006 May; 132(5):526-31. PubMed ID: 16702569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.